Jupiter Topco LLC Makes New Investment in CVS Health Corporation $CVS

Jupiter Topco LLC purchased a new stake in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 3,677,824 shares of the pharmacy operator’s stock, valued at approximately $380,460,000.

Other hedge funds also recently modified their holdings of the company. BlackRock Inc. bought a new position in CVS Health during the second quarter worth $12,747,462,000. State Street Corp raised its holdings in shares of CVS Health by 2.1% during the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the period. Capital International Investors boosted its position in shares of CVS Health by 3.4% during the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock worth $2,189,793,000 after purchasing an additional 900,153 shares in the last quarter. Norges Bank acquired a new stake in shares of CVS Health in the 4th quarter valued at about $1,666,265,000. Finally, Morgan Stanley increased its position in CVS Health by 6.3% in the 4th quarter. Morgan Stanley now owns 20,373,774 shares of the pharmacy operator’s stock valued at $1,616,863,000 after buying an additional 1,211,631 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 1.2%

CVS stock opened at $92.95 on Wednesday. The firm has a market capitalization of $118.88 billion, a PE ratio of 24.59, a P/E/G ratio of 0.86 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The stock’s 50 day moving average is $101.73 and its 200-day moving average is $89.20.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. CVS Health’s dividend payout ratio is currently 70.37%.

Analyst Ratings Changes

Several research analysts have issued reports on CVS shares. Sanford C. Bernstein increased their price target on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Barclays boosted their price objective on CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft increased their target price on CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Royal Bank Of Canada lifted their price target on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Finally, Wall Street Zen upgraded shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.